Skip to main content
OpenTrials
Completed

NCT Number: NCT01379352

Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia

The vecuronium requirements may be reduced for recipients of living donor liver transplantation, as the vecuronium is eliminated principally by the liver. Furthermore, the requirements may be different according to the phase of surgery. The requirements may also be different according to the preoperative hepatic function as measured by MELD score during prehepatic phase, or graft to recipient body weight ratio (GRWR) during neohepatic phase. Therefore, the investigators are trying to investigate the difference of vecuronium requirements according to the phase of surgery or MELD score, GRWR.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–69 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Samsung Medical Center

Seoul, 135-710, South Korea

About this study

The vecuronium requirements may be reduced for recipients of living donor liver transplantation, as the vecuronium is eliminated principally by the liver. Furthermore, the requirements may be different according to the phase of surgery. The requirements may by further reduced during anhepatic phase of liver transplantation. And the requirements may be increased as the graft functions during neohepatic phase.

We also postulated that the requirements may be different according to the preoperative hepatic function during preanhepatic phase, and according to the graft to recipient body weight ratio (GRWR) during neohepatic phase.

Therefore, we are trying to investigate the difference of vecuronium requirements according to the phase of surgery, MELD score, GRWR.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing elective living donor liver transplantation

Exclusion criteria

  • patients who can not undergo train-of-four test due to central or peripheral neuromuscular disease.
  • patients with severe cardiopulmonary diseases.
  • patients who received transfusion with more than 10 units of packed red blood cells.
  • primary non-functioning graft immediately after reperfusion of the graft.
  • patients who administered drugs that influences the metabolism of vecuronium (such as anticonvulsant: phenytoin, carbamazepine, primidone, sodium valproate)
  • patients undergoing cadaver donor liver transplantation

Treatment and study plan

Primary outcomes

  1. vecuronium requirements during preanhepatic phase

    Time frame: during prehepatic phase of liver transplantation

    total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during preanhepatic phase

  2. vecuronium requirements during anhepatic phase

    Time frame: during anhepatic phase of liver transplantation

    total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during anhepatic phase

  3. vecuronium requirements during neohepatic phase

    Time frame: during neohepatic phase of liver transplantation

    total vecuronium requirements as guided by Train-of-four neuromuscular monitoring during neohepatic phase

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Jun 23, 2011
Registry last updated
Dec 25, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.